U.S., Jan. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07356570) titled 'Second Prospective Cohort of Patients Entering the Multidisciplinary Care Pathway for Post-Covid Syndromes - SyPoCo2 Cohort' on June 12, 2025.

Brief Summary: The study aims to identify clinical profiles of long-COVID patients and correlate them with immunological and molecular data in order to identify prognostic biomarkers and potential therapeutic targets.

Study Start Date: June 13, 2025

Study Type: OBSERVATIONAL

Condition: Post-Acute COVID-19 Syndrome

Intervention: OTHER: Blood sample collection

A one-time 30 mL blood draw is performed during the inclusion visit for immunological and molecular analysis as part of the HERVC...